Cargando…

Time-Based Formulation Strategies for Colon Drug Delivery

Despite poor absorption properties, delivery to the colon of bioactive compounds administered by the oral route has become a focus of pharmaceutical research over the last few decades. In particular, the high prevalence of Inflammatory Bowel Disease has driven interest because of the need for improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Gazzaniga, Andrea, Moutaharrik, Saliha, Filippin, Ilaria, Foppoli, Anastasia, Palugan, Luca, Maroni, Alessandra, Cerea, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783935/
https://www.ncbi.nlm.nih.gov/pubmed/36559256
http://dx.doi.org/10.3390/pharmaceutics14122762
_version_ 1784857692444033024
author Gazzaniga, Andrea
Moutaharrik, Saliha
Filippin, Ilaria
Foppoli, Anastasia
Palugan, Luca
Maroni, Alessandra
Cerea, Matteo
author_facet Gazzaniga, Andrea
Moutaharrik, Saliha
Filippin, Ilaria
Foppoli, Anastasia
Palugan, Luca
Maroni, Alessandra
Cerea, Matteo
author_sort Gazzaniga, Andrea
collection PubMed
description Despite poor absorption properties, delivery to the colon of bioactive compounds administered by the oral route has become a focus of pharmaceutical research over the last few decades. In particular, the high prevalence of Inflammatory Bowel Disease has driven interest because of the need for improved pharmacological treatments, which may provide high local drug concentrations and low systemic exposure. Colonic release has also been explored to deliver orally biologics having gut stability and permeability issues. For colon delivery, various technologies have been proposed, among which time-dependent systems rely on relatively constant small intestine transit time. Drug delivery platforms exploiting this physiological feature provide a lag time programmed to cover the entire small intestine transit and control the onset of release. Functional polymer coatings or capsule plugs are mainly used for this purpose, working through different mechanisms, such as swelling, dissolution/erosion, rupturing and/or increasing permeability, all activated by aqueous fluids. In addition, enteric coating is generally required to protect time-controlled formulations during their stay in the stomach and rule out the influence of variable gastric emptying. In this review, the rationale and main delivery technologies for oral colon delivery based on the time-dependent strategy are presented and discussed.
format Online
Article
Text
id pubmed-9783935
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97839352022-12-24 Time-Based Formulation Strategies for Colon Drug Delivery Gazzaniga, Andrea Moutaharrik, Saliha Filippin, Ilaria Foppoli, Anastasia Palugan, Luca Maroni, Alessandra Cerea, Matteo Pharmaceutics Review Despite poor absorption properties, delivery to the colon of bioactive compounds administered by the oral route has become a focus of pharmaceutical research over the last few decades. In particular, the high prevalence of Inflammatory Bowel Disease has driven interest because of the need for improved pharmacological treatments, which may provide high local drug concentrations and low systemic exposure. Colonic release has also been explored to deliver orally biologics having gut stability and permeability issues. For colon delivery, various technologies have been proposed, among which time-dependent systems rely on relatively constant small intestine transit time. Drug delivery platforms exploiting this physiological feature provide a lag time programmed to cover the entire small intestine transit and control the onset of release. Functional polymer coatings or capsule plugs are mainly used for this purpose, working through different mechanisms, such as swelling, dissolution/erosion, rupturing and/or increasing permeability, all activated by aqueous fluids. In addition, enteric coating is generally required to protect time-controlled formulations during their stay in the stomach and rule out the influence of variable gastric emptying. In this review, the rationale and main delivery technologies for oral colon delivery based on the time-dependent strategy are presented and discussed. MDPI 2022-12-09 /pmc/articles/PMC9783935/ /pubmed/36559256 http://dx.doi.org/10.3390/pharmaceutics14122762 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gazzaniga, Andrea
Moutaharrik, Saliha
Filippin, Ilaria
Foppoli, Anastasia
Palugan, Luca
Maroni, Alessandra
Cerea, Matteo
Time-Based Formulation Strategies for Colon Drug Delivery
title Time-Based Formulation Strategies for Colon Drug Delivery
title_full Time-Based Formulation Strategies for Colon Drug Delivery
title_fullStr Time-Based Formulation Strategies for Colon Drug Delivery
title_full_unstemmed Time-Based Formulation Strategies for Colon Drug Delivery
title_short Time-Based Formulation Strategies for Colon Drug Delivery
title_sort time-based formulation strategies for colon drug delivery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783935/
https://www.ncbi.nlm.nih.gov/pubmed/36559256
http://dx.doi.org/10.3390/pharmaceutics14122762
work_keys_str_mv AT gazzanigaandrea timebasedformulationstrategiesforcolondrugdelivery
AT moutaharriksaliha timebasedformulationstrategiesforcolondrugdelivery
AT filippinilaria timebasedformulationstrategiesforcolondrugdelivery
AT foppolianastasia timebasedformulationstrategiesforcolondrugdelivery
AT paluganluca timebasedformulationstrategiesforcolondrugdelivery
AT maronialessandra timebasedformulationstrategiesforcolondrugdelivery
AT cereamatteo timebasedformulationstrategiesforcolondrugdelivery